+

AU2001286669A1 - Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes - Google Patents

Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes

Info

Publication number
AU2001286669A1
AU2001286669A1 AU2001286669A AU8666901A AU2001286669A1 AU 2001286669 A1 AU2001286669 A1 AU 2001286669A1 AU 2001286669 A AU2001286669 A AU 2001286669A AU 8666901 A AU8666901 A AU 8666901A AU 2001286669 A1 AU2001286669 A1 AU 2001286669A1
Authority
AU
Australia
Prior art keywords
hcv
hepatitis
antibodies
virus
peptide epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286669A
Inventor
Lance A. Liotta
Gordon Whiteley
Jonathan Zmuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001286669A1 publication Critical patent/AU2001286669A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001286669A 2000-08-23 2001-08-23 Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes Abandoned AU2001286669A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22725400P 2000-08-23 2000-08-23
US60/227,254 2000-08-23
PCT/US2001/026348 WO2002016946A2 (en) 2000-08-23 2001-08-23 ORAL FLUID RAPID ASSAY FOR HEPATITIS C VIRUS (HCV) ANTIBODIES USING NON-ANTIBODY LABELING OF IgA MOLECULES RECOGNIZING HCV PEPTIDE EPITOPES

Publications (1)

Publication Number Publication Date
AU2001286669A1 true AU2001286669A1 (en) 2002-03-04

Family

ID=22852386

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286669A Abandoned AU2001286669A1 (en) 2000-08-23 2001-08-23 Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes

Country Status (3)

Country Link
US (1) US20020150884A1 (en)
AU (1) AU2001286669A1 (en)
WO (1) WO2002016946A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7114403B2 (en) * 2003-05-30 2006-10-03 Oakville Hong Kong Co., Ltd Fluid collection and application device and methods of use of same
US20050106753A1 (en) * 2003-07-11 2005-05-19 Oakville Trading Hong Kong Limited Sanitary fluid collection, application and storage device and methods of use of same
EP1687608A4 (en) * 2003-11-14 2013-01-09 Alere Switzerland Gmbh Rapid sample collection and analysis device and methods of use
WO2007062575A1 (en) 2005-11-30 2007-06-07 Inverness Medical Switzerland Gmbh A device for detecting the presence or amount of an analyte in a fluid sample and method thereof
AU2007280929B2 (en) 2006-07-26 2012-03-22 Abbott Rapid Diagnostics International Unlimited Company Analysis device for biological sample
WO2011152793A1 (en) * 2010-06-02 2011-12-08 Mp Biomedicals Asia Pacific Pte Ltd Rapid multi-line hepatitis c virus assay
WO2013081933A1 (en) * 2011-11-28 2013-06-06 Tracker Llc Point of care immunization testing system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792605A (en) * 1996-07-05 1998-08-11 Ochnio; Jan J. Assay for Hepatitis A virus specific antibodies

Also Published As

Publication number Publication date
WO2002016946A2 (en) 2002-02-28
US20020150884A1 (en) 2002-10-17
WO2002016946A3 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
EP1366067A4 (en) Expression technology for proteins containing a hybrid isotype antibody moiety
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
AU2001272948A1 (en) Hcv antigen/antibody combination assay
EP1412538A4 (en) Methods for the simultaneous detection of hcv antigens and hcv antibodies
HUP0103650A3 (en) Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
AU2002235884A1 (en) Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
AU2001286669A1 (en) Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes
WO1995021922A3 (en) Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
AU2001276916A1 (en) Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
WO2003005026A3 (en) Chemical capture reagent
WO2004021871A3 (en) Hcv assay
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
WO2003020005A3 (en) Lp mammalian proteins; related reagents
EP1310796A3 (en) Reagents for the simultaneous detection of HCV core antigens and antibodies
ATE552264T1 (en) NEW SURFACE PROTEIN (HBSAG) VARIANT OF HEPATITIS B VIRUS
WO2003030624A3 (en) Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
WO2002074906A3 (en) Lp mammalian proteins; related reagents
AU2002223569A1 (en) Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
EP0870830A3 (en) Chimera hepatitis C virus antigen
WO2001093804A3 (en) Hepatitis c virus conjugates
CA2408174A1 (en) Hcv core protein sequences
IL137458A0 (en) Genetic immunization with nonstructural proteins of hepatitis c virus
WO2003022992A3 (en) Mammalian genes; related reagents
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载